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Maximum or Mean: That Is the Question
To the Editor:
Recently, Matsui et al1 suggested that maximum home systolic
blood pressure (SBP) might enhance the predictive value of
mean SBP in relation to hypertensive target organ damage in the
heart and arteries. However, the data presented do not wholly
substantiate the conclusions of Matsui et al.1 First, because of the
collinearity problem between maximum and mean SBP, the
results for the total population in Table 3 of their study1 should
have been omitted. Second, the reader is also left without any
information on the contribution of maximum SBP in explaining
the variance in left ventricular mass index and carotid intima-
media thickness, because in their Table 31 only the whole-model
R2 was given. Third, because of the cross-sectional design and
the use of intermediate signs of target organ damage, we suggest
that the term “prediction,” as used, for instance, in the conclusion
of their Abstract,1 is inappropriate. Finally, the maximum morn-
ing SBP was recorded during the first 3 days in more than one
third of the patients studied by Matsui et al.1 We find it
counterintuitive that a measurement obtained within 3 days of
self-measurement at home would be more closely associated
with target organ damage than the mean level of blood pressure
recorded over 14 days.
In trying to replicate the observations of Matsui et al,1 we
evaluated whether, in 2354 Ohasama participants2 followed up
for 12.1 years (median), maximum home SBP (single measure-
ments in the morning for 28 days) predicted cardiovascular
mortality (144 deaths). In multivariable-adjusted Cox regression,
the standardized hazard ratios associated with the maximum and
mean home SBP at home were 1.30 (95% CI: 1.08 to 1.57;
P0.006) and 1.28 (95% CI: 1.08 to 1.53; P0.006), respec-
tively. The correlation coefficient between maximum and mean
SBP was 0.91 (P0.001). Adding maximum home SBP, therefore,
did not improve a Cox model that included mean SBP, as indicated
by the likelihood ratio test (likelihood ratio: 0.49; P0.48) and vice
versa (likelihood ratio: 0.46; P0.50). In conclusion, we do not
believe that the results from Matsui et al1 overrule the current
recommendations to measure the home blood pressure over 73
days and to use the mean level for risk stratification.
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Response to Maximum or Mean: That Is the Question
We thank Asayama et al1 for their remarks about our recent
article2 and for showing their valuable data. We could not
perform a simple comparison of our results with those of the
Ohasama Study3 because there are several differences in the
subjects’ characteristics and study design between our study and
the Ohasama Study,2,3 as follows: (1) elderly untreated hyper-
tensives versus general population including treated hyperten-
sives; (2) the average age of the subjects (67 years versus 59
years); (3) the primary end point (target organ damage versus
cardiovascular mortality); and (4) the blood pressure (BP)
measurement schedule at home (3 times each in the morning and
evening for 2 weeks versus once in the morning over a period of
4 weeks). Here, we will try to answer the 4 main points raised in
their letter.
First, we think that Asayama et al1 misunderstood the analysis
of our article. As described in our Methods section, we did not
include the maximum home systolic BP (SBP) and mean home
SBP together in the same multivariable model because of
multicollinearity. Therefore, we think that the results for the total
population should not be omitted.
Second, the square of partial correlation coefficient of left
ventricular mass index was 0.104 (P0.001) in the total popu-
lation, 0.055 (P0.007) in the lower home BP group, and 0.086
(P0.001) in the higher home BP group; that of carotid
intima-media thickness was 0.084 (P0.001), 0.059 (P0.006),
and 0.083 (P0.001), respectively.
Third, we agree that the term “prediction” might have been
inappropriate in a cross-sectional study. In our article, we meant
to speculate on the presence of target organ damage from
maximum home SBP in hypertensive patients.
Fourth, although 39% of all subjects had their maximum home
SBP on the first 3 days, our results did not necessarily indicate
that home BPs during the first 3 days are sufficient for assess-
ment of the association between home BP and target organ
damage.
In addition, in this article, we did not deny the recommenda-
tion of the current home BP guideline4 to measure the home BP
over 7 days and to use the mean home BP level for risk
stratification. What we would like to emphasize here was that the
maximum value of home SBP could add further information
about the potential severity of target organ damages to the mean
level of home SBP. We are now prospectively studying the
predictive value of the maximum and mean home SBP for
cardiovascular mortality in our hypertensive cohort in an attempt
to clarify whether the significance of the maximum home SBP
may differ depending on the characteristics of the study subjects.
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